Experience in advanced RCC

7+ years of experience
since FDA approval
More than 45,000 patients*
have been treated with
TORISEL worldwide.1
*The total number of patients treated reflects an estimate based on the total number of TORISEL vials sold from June 2007 to September 2014 (based on IMS data). The number of unique patients is based on the average number of vials administered per month per patient, using an independent estimate conducted by IntrinsiQ, LLC from June 2008 to June 2013, and the average duration of treatment was derived from chart studies performed for Pfizer by Medimix International in 2011 and 2013.
  1. Data on file. Pfizer Inc, New York, NY.